In this talk, we’ll cover the promise, practice, and pitfalls of conducting psychotherapy with psychedelic medicines such as psilocybin, MDMA, and ketamine. (1) We’ll cover the key findings in scientific research in psychedelic science in the last fifteen years. We’ll discuss the broad implications of this new paradigm for the treatment of depression, suicidality, anxiety, trauma, etc. (2) We’ll discuss the various approaches to psychedelic psychotherapy, with a focus on the role of the clinician, pathways of healing, and spiritual and mystical experience. (3) We’ll outline common pitfalls, from the complications of “integration” to the “therapeutic bends,” and we will also critique the influence of money and ownership in psychedelic practice.
There is no template for the current COVID-19 induced world health and financial crisis. All of us are trying to maintain balance in an environment of unpredictability and threat. As part of our commitment to apply ancient wisdom and current science, mental health professionals within the Contemp...
The stage is set for a paradigm shift, do you feel it? Western culture has been dominated by the ideologies of materialism, reductionism, and objectivism rooted in the dangerous world-view of nihilism for three centuries and while we have seen great technological breakthroughs we are also now on ...
